Status:
COMPLETED
Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Asthma
Eligibility:
All Genders
6-11 years
Phase:
PHASE1
Brief Summary
To evaluate the safety, tolerability and plasma levels of single oral doses of MK0633 in pediatric asthma patients ages 6 to less than 12 years.
Eligibility Criteria
Inclusion
- Patient has mild to moderate asthma
- Patient is able to swallow pills
- Patient is able to have have blood draws
Exclusion
- Patient has required a visit to the hospital or emergency room due to an asthmatic event in the last 3 months
- Patient has an upper respiratory tract infection (URI)
- Patient has a history of stroke
- Patient consumes more than 4 caffeinated beverages per day
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00751413
Start Date
August 1 2008
End Date
January 1 2009
Last Update
June 1 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.